Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain, today ...

A coma is a prolonged state of unconsciousness where the brain slows significantly. Recovery depends on brain healing, with ...

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

As I have met with many parents these days, several parents shared their various concerns related to their children. To my surprise, one of the ...

People who use alcohol as a sleep aid often wake up feeling tired, groggy, or unrested due to disruptions in their sleep architecture, including reduced REM sleep, frequent awa ...

Discover how your heart's rhythm reveals stress levels, disease risk and fitness status and provides insights about your ...

TEDxMarshallU has announced the lineup of inspiring speakers for its 7th annual event, “Beyond Borders.” Eight speakers will ...

Including additional features, such as genetic markers, comorbid medical conditions, and psychosocial factors, may enhance the model’s ability to predict treatment outcomes. Multimodal data ...

This milestone follows the successful IRB approval, pilot testing and evaluation of Nexalin’s Halo technology at UCSD. The study will evaluate Nexalin’s proprietary Deep Intracranial Frequency ...